Suzhou Youyi Biotechnology raises Series A for serum-free cell culture media
What's the deal? Suzhou Youyi BiotechnologyDealroom has a profile for this one. Try Dealroom → has raised tens of millions of yuan in a Series A round.
Tianhui CapitalDealroom has a profile for this one. Try Dealroom → and Nanomicro Technology co-led the round, with Dongyun Venture CapitalDealroom has a profile for this one. Try Dealroom → also participating.
The company develops and produces serum-free cell culture media. It also researches cosmetic ingredients.
Why now? Serum-free media is a critical input for biopharma and cell therapy, fields where China is racing to cut reliance on imported supplies.
Domestic alternatives are in demand as biotech manufacturers seek cheaper, locally sourced materials.
What could go wrong? Serum-free media is a technically demanding niche dominated by established global players.
Youyi must prove its products can match imported quality at scale to win over cautious manufacturers.
The signal: Backing from Nanomicro Technology, a corporate investor rather than a pure financial fund, points to strategic interest in securing domestic bioprocessing inputs. For an early-stage company like Suzhou Youyi, that kind of industry-aligned backer can be as valuable as the capital itself in winning over cautious manufacturers.
